Robert Jeffrey Karnes, MD

  • 10988 Citations
  • 56 Scopus h-Index
20002020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Robert Jeffrey Karnes is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

AUTHOR REPLY

Lyon, T. D., Shah, N. D., Tollefson, M. K., Shah, P. H., Sangaralingham, L. R., Asante, D., Thompson, R. H., Karnes, R. J., Frank, I. & Boorjian, S. A., Feb 2020, In : Urology. 136, 1 p.

Research output: Contribution to journalComment/debate

Genomic and clinical characterization of stromal infiltration markers in prostate cancer

Mahal, B. A., Alshalalfa, M., Zhao, S. G., Beltran, H., Chen, W. S., Chipidza, F., Davicioni, E., Karnes, R. J., Ku, S. Y., Lotan, T. L., Muralidhar, V., Rebbeck, T. R., Schaeffer, E. M., Spratt, D. E., Feng, F. Y. & Nguyen, P. L., Apr 1 2020, In : Cancer. 126, 7, p. 1407-1412 6 p.

Research output: Contribution to journalArticle

  • Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high-risk men

    Assel, M. J., Ulmert, H. D., Karnes, R. J., Boorjian, S. A., Hillman, D. W., Vickers, A. J., Klee, G. G. & Lilja, H., Jan 1 2020, In : Prostate. 80, 1, p. 51-56 6 p.

    Research output: Contribution to journalArticle

  • Outcomes of Salvage Radical Prostatectomy for M0 Castration-resistant Recurrent Prostate Cancer: A Reasonable Option in the Era of New Antiandrogen Therapies?

    Marra, G., Calleris, G., Alessio, P., Oderda, M., Palou, J., Joniau, S., Piechaud, T., Smelzo, S., Morlacco, A., Sharma, V., Tilki, D., Van der Poel, H., Veerman, H., Karnes, R. J. & Gontero, P., Jan 1 2020, (Accepted/In press) In : European Urology Focus.

    Research output: Contribution to journalArticle

  • Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier

    Tosoian, J. J., Birer, S. R., Jeffrey Karnes, R., Zhang, J., Davicioni, E., Klein, E. E., Freedland, S. J., Weinmann, S., Trock, B. J., Dess, R. T., Zhao, S. G., Jackson, W. C., Yamoah, K., Pra, A. D., Mahal, B. A., Morgan, T. M., Mehra, R., Kaffenberger, S., Salami, S. S., Kane, C. & 7 others, Pollack, A., Den, R. B., Berlin, A., Schaeffer, E. M., Nguyen, P. L., Feng, F. Y. & Spratt, D. E., Jan 1 2020, (Accepted/In press) In : Prostate Cancer and Prostatic Diseases.

    Research output: Contribution to journalArticle